Back
First Citizens BancShares, Inc. (North Carolina) 10K Form
Buy
59
FCNCA
First Citizens BancShares, Inc. (North Carolina)
Last Price:
$2,181.76
Seasonality Move:
1.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FCNCA News And Ratings
See the #1 stock for the next 7 days that we like better than FCNCA
FCNCA Financial Statistics
Sales & Book Value
| Annual Sales: | $14.9B |
|---|---|
| Cash Flow: | $541M |
| Price / Cash Flow: | 18.72 |
| Annual Sales: | $1,672.53 |
| Price / Book: | 1.29 |
Profitability
| EPS (TTM): | 169.15210 |
|---|---|
| Net Income (TTM): | $2.3B |
| Gross Margin: | $0 |
| Return on Equity: | 10.42% |
| Return on Assets: | 1.02% |
First Citizens BancShares, Inc. (North Carolina) Earnings Forecast
Key First Citizens BancShares, Inc. (North Carolina) Financial Ratios
-
The Gross Profit Margin over the past 41 years for FCNCA is 0.00%.
-
The Selling, General & Administrative Expenses for FCNCA have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 48.40% of Operating Income.
-
The Net Earning history of FCNCA is 18.60% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 23 years.
First Citizens BancShares, Inc. (North Carolina) Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Banks |
| Sector: | Financials |
| Current Symbol: | FCNCA |
| CUSIP: | 31946M |
| Website: | firstcitizens.com |
Debt
| Debt-to-Equity Ratio: | 1.77 |
|---|---|
| Current Ratio: | 0.29 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.53 |
|---|---|
| Forward P/E Ratio: | 11.74 |
FCNCA Technical Analysis vs Fundamental Analysis
Buy
59
First Citizens BancShares, Inc. (North Carolina) (FCNCA)
is a Buy
Is First Citizens BancShares, Inc. (North Carolina) a Buy or a Sell?
-
First Citizens BancShares, Inc. (North Carolina) stock is rated a BuyThe current First Citizens BancShares, Inc. (North Carolina) [FCNCA] share price is $2,183.12. The Score for FCNCA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.